NCT03220191View on ClinicalTrials.gov

Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

September 3, 2017

Study Completion Date

September 26, 2017

Conditions

Healthy Volunteer

Interventions

DRUG

Palbociclib

palbociclib tablet formulation

DRUG

Rabeprazole

rabeprazole as PPI

Trial Locations (1)

06511

Pfizer New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY